Literature DB >> 2943288

Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.

D Kessel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943288     DOI: 10.1016/0006-2952(86)90196-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  9 in total

1.  Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell lines.

Authors:  E Roller; B Klumpp; J Krause; M Eichelbaum; K Schumacher
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 2.  Anthracycline antibiotics in cancer therapy. Focus on drug resistance.

Authors:  D J Booser; G N Hortobagyi
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

3.  Reversal of acquired resistance to adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: role of drug interaction with alpha 1 acid glycoprotein.

Authors:  M Chatterjee; A L Harris
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

4.  Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein.

Authors:  S P Cole; H F Downes; M L Slovak
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

5.  Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.

Authors:  M Sehested; T Skovsgaard; P B Jensen; E J Demant; E Friche; N Bindslev
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

6.  High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines.

Authors:  N S Stuart; P Philip; A L Harris; K Tonkin; S Houlbrook; J Kirk; E A Lien; J Carmichael
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

7.  Interaction of tamoxifen with the multidrug resistance P-glycoprotein.

Authors:  R Callaghan; C F Higgins
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

8.  Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell line.

Authors:  Y Urasaki; T Ueda; T Nakamura
Journal:  Jpn J Cancer Res       Date:  1994-06

9.  Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites.

Authors:  J Kirk; S Houlbrook; N S Stuart; I J Stratford; A L Harris; J Carmichael
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.